Table 4.
Prevalence of psychiatric diagnoses.
| SCID-5 disorder category | Sample Prevalence n (%) | |
|---|---|---|
| Lifetime | Current | |
| PTSD* | 78 (42.2%) | 47 (25.4%) |
| Other anxiety disorders | 35 (18.9%) | 26 (14.1%) |
| Mood disorders** | 99 (53.5%) | 42 (22.7%) |
| Substance use disorders (Alcohol & Drug)*** | 112 (60.5%) | 40 (21.6%) |
| Schizophrenia psychotic disorders**** | 3 (1.6%) | 2 (1.1%) |
| Eating disorders | 5 (2.7%) | 2 (1.1%) |
| Sleep disorders | – | 22 (11.9%) |
| Other SCID-5 disordersa,b | 7 (3.8%) | 25 (15.5%) |
Other Lifetime Disorders include: Other Specified Trauma- and Stressor-Related Disorder, Hoarding Disorder, Body Dysmorphic Disorder, and Other DSM-5 Disorder.
Other Current Disorders include: Adult Attention-deficit/Hyperactivity Disorder, Intermittent Explosive Disorder, Other Specified Trauma- and Stressor-Related Disorder, Acute Stress Disorder, Hoarding Disorder, Gambling Disorder, Body Dysmorphic Disorder, Somatic Symptom Disorder, and Other DSM-5 Disorder.
National PTSD prevalence estimates lifetime and past 6 months, 9.4%, 4.2% (Kilpatrick et al., 2013).
US adults past year prevalence, major depressive episode and bipolar disorder, 6.7% and 2.8%, respectively (Center for Behavioral Health Statistics and Quality, 2017)
US national prevalence rates of Drug Use Disorders, lifetime and past 12 months, 9.9% and 3.9%, respectively (sedative/tranquilizer, cannabis, amphetamine, cocaine, nonheroin opioid, heroin, hallucinogen, club drug [e.g., ecstasy, ketamine], and solvent/inhalant use disorders) (Grant et al., 2016). Past 12-month heavy alcohol users, 6.2%, age 12 and older (Center for Behavioral Health Statistics and Quality, 2015).
Worldwide 12-month and lifetime prevalence of schizophrenia (median estimate), 0.33% and 0.48%, respectively (Simeone et al., 2015).